Impact and Efficacy of Topical Dry Mouth Products in Haemodialysis Patients with Xerostomia: A Pilot Study
2020

Efficacy of Dry Mouth Products in Dialysis Patients

Sample size: 25 publication 10 minutes Evidence: moderate

Author Information

Author(s): López-Pintor Rosa María, López-Pintor Lucía, González-Serrano José, Casañas Elisabeth, de Arriba Lorenzo, Hernández Gonzalo

Primary Institution: Complutense University of Madrid

Hypothesis

The xerostomia treatment with these products could decrease xerostomia, reducing IDWG and improving quality of life.

Conclusion

Topical treatment for xerostomia can improve the quality of life and reduce thirst and IDWG in haemodialysis patients.

Supporting Evidence

  • 80% of patients showed improvement in xerostomia after 2 weeks.
  • 92% of patients showed improvement in xerostomia after 4 weeks.
  • Total xerostomia scores decreased from 42.64 to 20.22 after 4 weeks.
  • Quality of life improved significantly as measured by OHIP-14 scores.
  • IDWG decreased significantly after 2 weeks and maintained reduction at 4 weeks.

Takeaway

This study shows that using special mouth products can help people on dialysis who have dry mouth feel better and drink less water.

Methodology

25 haemodialysis patients used toothpaste, mouthwash, and mouth gel for 4 weeks, with assessments at baseline, 2 weeks, and 4 weeks.

Potential Biases

Potential bias due to lack of a control group and the small sample size.

Limitations

The study design was a pilot without a placebo group, and the treatment duration was short.

Participant Demographics

56% male, 44% female, mean age 63.52 years.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3290/j.ohpd.b871063

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication